Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

FedEx Faces Price Target Cuts By Analysts Following Q1 Results, Shares Slide

FedEx Corporation (NYSE: FDX) said its adjusted earnings per share dropped to $3.44 for the quarter ended Aug 31 compared to $4.37 in the year-ago period, while revenue increased to $23.2 billion from $22 billion.
byLisa Levin
September 23, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

FedEx Corporation (NYSE:FDX) said its adjusted earnings per share dropped to $3.44 for the quarter ended Aug 31 compared to $4.37 in the year-ago period, while revenue increased to $23.2 billion from $22 billion.

FedEx also announced plans to repurchase $1.5 billion of its common stock during fiscal 2023. The company said it plans to repurchase $1 billion of its common stock in the second quarter.

FedEx shares slipped 2.8% to $150.25 in the pre-market trading session.

These analysts made changes to their price targets on FedEx following the release of results.

  • Credit Suisse cut price target on FedEx from $246 to $236. Credit Suisse analyst Ariel Rosa maintained the stock with an Outperform.
  • B of A Securities lowered FedEx price target from $186 to $178. B of A Securities analyst Ken Hoexter maintained the stock with a Neutral.
  • BMO Capital cut FedEx price target from $215 to $190. BMO Capital analyst Fadi Chamoun maintained a Market Perform rating on the stock.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

NBA Legend Isiah Thomas Says Colombia’s ‘Regulatory And Political Hurdles’ Are Not Affecting His Cannabis Business

By Jelena Martinovic
February 5, 11:00 AM
The legalization of marijuana in Colombia has been delayed after the Senate members put a halt to its implementation. The decision is expected to prompt lawmakers to start the legislative process again if they wish to continue with the proposed reforms to legalize cannabis. However, the lack of regulatory changes in marijuana laws is not affecting One World Products' operations or business prospects. The company recently agreed a deal to manufacture the Smokiez Gummies for distribution in the US, Europe and South America. It also signed an agreement with Kx Family Care to produce and distribute its CBD-enriched product range in Colombia and other Latin American countries. One World said both agreements are on track and will undergo production and commercialization soon. Further attempts will be made to legalize marijuana in Colombia within the next six months.

OWPC

Read More

Deciphera Pharmaceuticals Presents Long-Term Follow-Up Results From INTRIGUE Phase 3 Clinical Study In Second-Line GIST Patients At The 2024 American Society Of Clinical Oncology Gastrointestinal Cancers Symposium

By Benzinga Newsdesk
January 18, 12:14 PM
– Median Overall Survival for QINLOCK® of 35.5 Months Versus 31.5 Months for Sunitinib in the All-Patient Intent-to Treat-Population –– Long-Term Safety Profile Consistent with Primary Analysis Showing Fewer

DCPH